Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00153634 · ClinicalTrials.gov registry record · NA
Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)
A NA study, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT00153634: Completed NA study, sponsored by Seattle Children's Hospital.
NCT00153634 is a NA study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00153634, a NA study, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
This was a randomized multi-center clinical trial to compare the microbiological efficacy, clinical efficacy, and safety of using standard versus biofilm susceptibility testing of P. aeruginosa sputum isolates to guide antibiotic selection for treatment of airway infection in clinically stable patients with CF.
Interventions
- DRUG IV amikacin
- DRUG PO azithromycin
- DRUG IV ceftazidime
- DRUG PO ciprofloxacin
- DRUG IV meropenem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2004-03 |
| Est. Completion | 2007-11 |
| Phase | NA |
What the finished NCT00153634 record still lists
NCT00153634 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 5 interventions - of which IV amikacin is the first listed.
NCT00153634 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00153634 about?
NCT00153634 is a clinical study titled "Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)". This was a randomized multi-center clinical trial to compare the microbiological efficacy, clinical efficacy, and safety of using standard versus biofilm susceptibility testing of P. aeruginosa sputum isolates to guide antibiotic selection for treatment of airway infection in clinically stable patie...
What is the current status of trial NCT00153634?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2004-03. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00153634?
The interventions under investigation include: IV amikacin (DRUG), PO azithromycin (DRUG), IV ceftazidime (DRUG), PO ciprofloxacin (DRUG), IV meropenem (DRUG).
Who is sponsoring clinical trial NCT00153634?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00153634's enrollment target sits among peer trials
75 1069th of 2000 higher than 919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia